- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
UK's Cancer Drugs Fund Will Improve Access But Evaluate Value
While the 40% funding boost will help patients continue current expensive treatment, or improve access for others, determining "value for money" is high on the NHS agenda.
Pioneering cancer drugs will not be made available under a flagship scheme founded by David Cameron if they do not represent good value for money.
Jeremy Hunt, the Health Secretary, will on Thursday boost funding for the flagship Cancer Drugs Fund by 40 per cent to almost £300 million a year.
The move will give thousands more cancer patients access to cutting-edge cancer drugs which would otherwise be deemed too expensive for the NHS.
Under new plans clinicians will examine whether the drugs on offer are the most effective available to ensure "this extensive additional funding is spent in the best way for patients".
No patients will have any current treatments terminated, and patients with rare conditions who have no other option will continue to get access to the most effective drugs. Officials believe that the move will give the NHS more bargaining power and help reduce the prices of drugs.
Read the complete report: http://bit.ly/1qmVcl0
Source: The Telegraph
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care
November 13th 2024Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Read More
